Literature DB >> 8459239

Urinary symptoms and the neurological features of bladder dysfunction in multiple sclerosis.

C D Betts1, M T D'Mellow, C J Fowler.   

Abstract

One hundred and seventy patients with multiple sclerosis and bladder dysfunction were evaluated. Emphasis was placed on the relationship between their neurological features and urinary symptoms. The severity of the urinary symptoms was related to the degree of pyramidal impairment in the lower limbs so that both problems are thought to reflect the extent of spinal involvement. No other neurological features correlated with bladder dysfunction. Detrusor hyperreflexia was the commonest finding on cystometry and no patient had areflexia. More than half of the patients had a significantly raised post-micturition residual volume but symptoms were largely unreliable in predicting poor bladder emptying. In this series only two patients had evidence of upper tract disease: both men with severe, longstanding neurological disease who had indwelling catheters. Detrusor hyperreflexia can be anticipated in patients with MS who have irritative urinary symptoms and pyramidal signs in their lower limbs. After measurement of the residual volume appropriate treatment can be instituted.

Entities:  

Mesh:

Year:  1993        PMID: 8459239      PMCID: PMC1014855          DOI: 10.1136/jnnp.56.3.245

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  33 in total

1.  MULTIPLE SCLEROSIS: A CURRENT APPRAISAL OF SYMPTOMS AND SIGNS.

Authors:  R R IVERS; N P GOLDSTEIN
Journal:  Proc Staff Meet Mayo Clin       Date:  1963-10-09

2.  BLADDER DYSFUNCTION IN MULTIPLE SCLEROSIS.

Authors:  H MILLER; C A SIMPSON; W K YEATES
Journal:  Br Med J       Date:  1965-05-15

3.  Pontine pathology and voiding dysfunction.

Authors:  C D Betts; R Kapoor; C J Fowler
Journal:  Br J Urol       Date:  1992-07

4.  The Cerebral Control of Micturition.

Authors:  J Andrew; P W Nathan
Journal:  Proc R Soc Med       Date:  1965-07

5.  Cystometric and sphincter abnormalities in multiple sclerosis.

Authors:  W E Bradley; J L Logothetis; G W Timm
Journal:  Neurology       Date:  1973-10       Impact factor: 9.910

6.  Vesical dysfunction in multiple sclerosis.

Authors:  S E Gonor; D J Carroll; J B Metcalfe
Journal:  Urology       Date:  1985-04       Impact factor: 2.649

Review 7.  Central neural control of the lower urinary tract.

Authors:  W C de Groat
Journal:  Ciba Found Symp       Date:  1990

8.  Neuro-muscular dysfunction of the lower urinary tract in multiple sclerosis.

Authors:  H Van Poppel; R L Vereecken; A Leruitte
Journal:  Paraplegia       Date:  1983-12

9.  Urodynamic patterns in multiple sclerosis.

Authors:  H W Schoenberg; J Gutrich; J Banno
Journal:  J Urol       Date:  1979-11       Impact factor: 7.450

10.  Relationship between neurological and urological status in patients with multiple sclerosis.

Authors:  S A Awad; J B Gajewski; S K Sogbein; T J Murray; C A Field
Journal:  J Urol       Date:  1984-09       Impact factor: 7.450

View more
  47 in total

1.  Urologic manifestations of multiple sclerosis: proposed treatment algorithms.

Authors:  G A Barbalias; E N Liatsikos; C Passakos; D Barbalias; G Sakelaropoulos
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

2.  Clinical management of the neurourological syndrome associated with multiple sclerosis and correlations to grade of the disease.

Authors:  G A Barbalias; E N Liatsikos; C Passakos; D Barbalias; G Sakelaropoulos
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

Review 3.  Outcomes assessment of drug treatment in multiple sclerosis clinical trials.

Authors:  M Malone; B Lomaestro
Journal:  Pharmacoeconomics       Date:  1996-03       Impact factor: 4.981

Review 4.  Underactive Bladder.

Authors:  Himanshu Aggarwal; Philippe E Zimmern
Journal:  Curr Urol Rep       Date:  2016-03       Impact factor: 3.092

5.  The TRUST (EvaluaTion of Bladder Function in Relapsing-Remitting MUltiple Sclerosis Patients Treated with Natalizumab) Observational Study.

Authors:  Bhupendra O Khatri; John F Foley; Jennifer Fink; John F Kramer; Choon Cha; Xiaojun You; John D Warth; Pam Foulds
Journal:  Int J MS Care       Date:  2014

Review 6.  Vesicourethral dysfunction in multiple sclerosis. Initial assessment based on lower urinary tract symptoms and their pathophysiology.

Authors:  Paolo Di Benedetto; Cristina Delneri; Emanuele Biasutti; Luisa Monti Bragadin; Tullio Giorgini
Journal:  Neurol Sci       Date:  2008-12       Impact factor: 3.307

Review 7.  Botulinum neurotoxin-A treatment of lower urinary tract symptoms in multiple sclerosis.

Authors:  Oussama El Yazami Adli; Jacques Corcos
Journal:  Can Urol Assoc J       Date:  2014-01       Impact factor: 1.862

8.  Bladder dysfunction in acute transverse myelitis: magnetic resonance imaging and neurophysiological and urodynamic correlations.

Authors:  J Kalita; S Shah; R Kapoor; U K Misra
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-08       Impact factor: 10.154

9.  Prevalence of bowel dysfunction in patients with multiple sclerosis and bladder dysfunction.

Authors:  Y W Chia; C J Fowler; M A Kamm; M M Henry; M C Lemieux; M Swash
Journal:  J Neurol       Date:  1995-01       Impact factor: 4.849

10.  Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances.

Authors:  A Ghezzi; E Mutta; F Bianchi; S Bonavita; F Buttari; A Caramma; R Cavarretta; D Centonze; G C Coghe; G Coniglio; U Del Carro; M T Ferrò; M G Marrosu; F Patti; M Rovaris; M Sparaco; I Simone; C Tortorella; R Bergamaschi
Journal:  Neurol Sci       Date:  2015-11-27       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.